Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents

Abstract

AimIt is important to consider hypoglycemia for glycemic control in elderly patients with type 2 diabetes. Continuous blood glucose monitoring system is an effective method to investigate blood glucose fluctuation. This study examined hypoglycemia frequency using continuous blood glucose monitoring system in older patients with type 2 diabetes.MethodsA total of 70 patients with type 2 diabetes aged >65 years, receiving oral treatment only and having a glycated hemoglobin (HbA1c) level of <8% were enrolled. Flash glucose monitoring system was used for the device. Patients were classified into three groups according to the type of medicine administered, in addition to other oral hypoglycemics, and were compared: (i) those taking sulfonylureas (SU); (ii) those taking glinides; and (iii) those who did not take either SU or glinides.ResultsThere was a significant positive correlation between the coefficient of variation and hypoglycemic frequency in all the patients, and a significant negative correlation between HbA1c and hypoglycemia in those receiving SU. When hypoglycemia was defined as glucose levels <54 mg/dL and <70 mg/dL, the cut‐off HbA1c values for developing hypoglycemia were 6.3% and 6.7%, sensitivity was 75.0% and 76.2%, and specificity was 90.9% and 77.6%, respectively.ConclusionsIn older patients with type 2 diabetes receiving SU, hypoglycemic frequency increases with decreases in HbA1c level. In particular, in patients with HbA1c levels of <6.3% receiving SU, it is necessary to consider medication modification. Geriatr Gerontol Int 2019; 19: 1030–1035.

Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta‐analysis

“…4 -Forest plot for all included studies of fracture risk who treated with Sulfonylurea and those with Metformin. Hypoglycemia has been one of the many concerning side effects among patients receiving sulfonylurea [28]. Therefore, we speculate that hypoglycemia and increased risk of falls may be the cause of sulfonylureas-induced fractures.…”

Potentially Inappropriate Medication and Associated Factors Among Older Patients with Chronic Coronary Syndrome at Hospital Discharge in Beijing, China

“…50 A Japanese study has suggested sulfonylurea conversion when HbA1c < 6.3% or 6.7% in older diabetic patients. 51 Patients receiving glimepiride should be educated with regular monitoring of blood glucose and HbA1c.…”

Nocturnal hypoglycemia is underdiagnosed in older people with insulin‐treated type 2 diabetes: The HYPOAGE observational study

“…23 The frequency of hypoglycemia in our study was concordant or even slightly higher than in previously published studies in older patients with T2D, including recent studies with CGM. 9,10,17,24 There are two potential explanations for this observation. First, the HYPOAGE population was older and under insulin therapy.…”